Cost-effectiveness analysis of phenotypic-guided versus guidelines-guided bronchodilator therapy in viral bronchiolitis.

Carlos E Rodriguez-Martinez Gustavo Nino Jose A Castro-RodriguezGeovanny F PerezMonica P Sossa-BriceñoJefferson Antonio Buendia

Published in: Pediatric pulmonology (2020)

Compared to guidelines-guided strategy, treating infants with viral bronchiolitis using the phenotypic-guided bronchodilator therapy strategy is a more cost-effective strategy, because it involves a lower probability of hospital admission at lower total treatment costs.

Keyphrases

sars cov
emergency department
clinical practice
healthcare
respiratory syncytial virus
cell therapy
acute care
adverse drug